Upgrade to SI Premium - Free Trial

Repligen (RGEN) Tops Q4 EPS by 8c, Beats on Revenues; Offers FY18 EPS/Revenues Mid-Point Guidance Below Consensus

February 22, 2018 7:36 AM

Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.20, $0.08 better than the analyst estimate of $0.12. Revenue for the quarter came in at $41.6 million versus the consensus estimate of $41.15 million.

Fourth Quarter 2017 Snapshot

Financial Guidance for 2018

Based on our current projections, we are providing financial guidance for the year 2018. This guidance is based on expectations for our existing business and does not include the financial impact of potential new acquisitions or future fluctuations in foreign currency exchange rates.

Our guidance for 2018 includes the first full year of sales following our acquisition of Spectrum on August 1, 2017.

YEAR 2018 GUIDANCE:

Our non-GAAP guidance for the year 2018 excludes the following items:

Our non-GAAP guidance for the year 2018 includes:

GUIDANCE:

Repligen sees FY2018 EPS of $0.68-$0.72, versus the consensus of $0.72. Repligen sees FY2018 revenue of $180-186 million, versus the consensus of $184.2 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

Categories

Earnings Guidance Hot Guidance